Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. - Wikidata - awgldk - TriplyDB

Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.

Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.

http://www.wikidata.org/entity/Q33639389

about

Mild cognitive impairment: pathology and mechanisms.G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration Rab GTPases, membrane trafficking and diseases Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome Plasma BDNF levels vary in relation to body weight in females Zebrafish Rab5 proteins and a role for Rab5ab in nodal signalling.Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein.Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.Deep sleep and parietal cortex gene expression changes are related to cognitive deficits with age.Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.Epigenetic memory: the Lamarckian brain Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology.Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).Autophagy failure in Alzheimer's disease--locating the primary defect.Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.A systems biology investigation of neurodegenerative dementia reveals a pivotal role of autophagy.Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.Hippocampal endosomal, lysosomal, and autophagic dysregulation in mild cognitive impairment: correlation with aβ and tau pathology Hook proteins: association with Alzheimer pathology and regulatory role of hook3 in amyloid beta generation 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.Age-related neurodegeneration and memory loss in down syndrome.Significance of transcytosis in Alzheimer's disease: BACE1 takes the scenic route to axons.Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's Disease.

P2860

Q24631255-350B022E-9460-4FCE-9F88-A25BC0DF61FB Q26752403-32733E18-F716-47D8-8F98-3C9EBC1F6ACD Q26785986-0E582D36-1091-4B01-AC85-276EE51C0186 Q27000356-5F21979A-5B2A-454B-A6C9-CECB30FD7BAF Q27007041-12F3C23F-0903-428E-87AE-363F9DB97B4B Q27331605-4AAAA973-4B94-4923-888C-B2E417A8090C Q27687621-295FDCE6-0BFE-42B4-88AC-D476BA0957DD Q28118988-418460AB-B911-41B1-ABD7-E20B5338898C Q28478524-764257F6-FD68-4C2C-942A-0D18B556E251 Q28542515-39E6AA56-8898-471C-A0D1-00FADFE27E6D Q28727632-9435CEF4-D9F7-4072-9BD9-C4EA12DEDAC8 Q30615569-A84D3F80-B6F9-41E8-AE77-3F74B1A7DE6A Q30835713-3C9C1CA3-F21C-4CF9-89B1-DB241CA648F4 Q31023394-F3945A84-4111-4474-9EAC-B1A59F66F5B0 Q33603071-DE03EE56-3AA7-46D4-939D-43100092DE46 Q33792226-27678279-CC57-444A-B2C4-62E306C6E90F Q33869293-EC870DF6-2515-406F-BDEF-1ECD9A1549ED Q33984420-F7674171-03B7-4A95-A432-8D6D1A102C0D Q34073334-917D0017-2FF6-4C74-818E-C80CDDEE8C49 Q34323841-1F878556-F9A5-44A1-8BC8-E6C6EDAAB277 Q34514070-58A0C758-2EC7-4868-AE69-510AB7DD38DF Q34543633-675BBB38-317E-494A-9023-225EFCD3D739 Q34548561-51BF3DFB-31EA-4F11-80C3-A5E7D737AA2F Q34950366-7ECC7906-559E-4CB0-8E31-1558C3BFFBE6 Q34979826-4EA05E19-6B45-4166-9E5A-25020EEF6AB1 Q34987827-D197DAA0-1AE6-4BA8-B58A-4DD6222AB532 Q35118876-40146D7A-D3D3-4CCE-B012-084342ECD6DD Q35137488-02364507-A29E-491D-9876-0C885F6CC4AB Q35162941-A268E198-E826-4C05-9F32-3A29D3D885C2 Q35183471-33A92476-992F-48D6-AB42-E27276C134EC Q35186435-C399C5AB-22AA-4B6D-B4C2-F0A4442207ED Q35196299-3D62C96E-93EB-46A8-BBF8-CB9C85928E7D Q35208328-688D987C-8447-49ED-B74D-765A7BF11341 Q35622640-801AB3EC-BFCA-4514-9C35-8783265168A0 Q35661134-32711BC6-D28E-40CC-906D-D0B8CE7D34CE Q35710041-6385D5E1-1935-492E-A080-50BE88D7543B Q35753185-3EDFB670-E3AB-4995-A6DC-8939913D6DE5 Q35867093-65A98CAF-7913-4184-A75B-FEF7B6F1BE08 Q35883077-FBD40509-5514-445F-97B7-6B52D51A11AB Q35894510-0A6BC83A-0F60-46F8-BA5C-BD1F0A55DC7F

P2860

Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.

http://www.wikidata.org/entity/Q33639389

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Microarray analysis of hippoca ...... zheimer's disease progression.

@ast

Microarray analysis of hippoca ...... zheimer's disease progression.

@en

type

label

Microarray analysis of hippoca ...... zheimer's disease progression.

@ast

Microarray analysis of hippoca ...... zheimer's disease progression.

@en

prefLabel

Microarray analysis of hippoca ...... zheimer's disease progression.

@ast

Microarray analysis of hippoca ...... zheimer's disease progression.

@en

P1433

Q33639389-4613A501-D855-4BE8-89DE-DE306155F394

P1476

Q33639389-211B0973-4FF6-49DD-990D-E5EB2B67EDE5

P2093

Q33639389-01C515D8-D9F4-4444-ABAA-50F0F1931DEE

Q33639389-063EBB6D-5DC9-49CA-96B2-D14947D6D414

Q33639389-2A837644-60BA-4547-80FD-FE793AF85A93

Q33639389-391FE58B-8F85-41F8-B0EE-33566C3FB0FA

Q33639389-5A7BC2B0-4263-4168-AF93-7E30E1D13795

Q33639389-933CAB7F-73BB-4EDE-AC2E-3CB3593108D1

Q33639389-961FF7B7-943E-4153-8F62-DC7384CC5EE5

Q33639389-AE83D753-F013-4D95-9051-7427CAF6A971

Q33639389-FAD99D71-AFF8-4433-AE28-78D032F4E363

P2860

Q33639389-036CD4BF-6E5E-4771-A69F-7B359EBF89CB

Q33639389-061E087E-F41E-4EB1-8645-08EFDD4E0B38

Q33639389-24226D93-171F-4F66-8A7C-040B8FCFDE69

Q33639389-242FF8E7-5D07-4DA6-A7CB-60F0CCE8F4BF

Q33639389-2AB011E4-CAE4-4166-86B9-1870D89AC282

Q33639389-2B0B27C4-BFC0-43D5-B7D0-2505BE2D3E9F

Q33639389-35D2F459-0C4A-4BB4-98D3-F204BC8462B8

Q33639389-374793AE-F22E-4C42-A7DE-67EDFC66AF0E

Q33639389-37DFC515-55E8-47B5-8C65-A67B65894A12

Q33639389-442DD0B9-D82D-45D9-B52F-5816C6BB6DBB

P304

Q33639389-4AFB9D54-D192-418E-AF41-A0A8CE9D99D0

P31

Q33639389-3B278D42-E99E-4ECE-A31A-F7B4DFCB0457

P356

Q33639389-9E5BB9CD-8F82-49CF-AF58-48099CECE2F0

P407

Q33639389-30D95FB9-1D98-4862-AAE3-86D4CCC310E2

P433

Q33639389-BE46FEC2-0EC4-4092-AB46-E3668F2139E2

P478

Q33639389-1F50D8AB-0B6B-4FE3-ACFF-B40D8C2628B6

P50

Q33639389-5E9A8A30-3A3B-4B36-8F81-60A64F3E1D89

Q33639389-7E8CCCDE-7C69-4E67-9B21-C8A3B3FC7339

P577

Q33639389-DCC0D416-390D-4D9E-9A72-9F6A95E21B80

P5875

Q33639389-4E787C71-AAED-4043-9ECD-8F6B05F1E0AC

P698

Q33639389-FC4C213B-DC40-4E01-A788-AFA4F6ABDBF4

P921

Q33639389-D18BF1A3-2D08-4021-8958-BFADD7EEC2D8

P932

Q33639389-E119C901-B17E-4126-B3FB-A627BBE2C9D7

P356

J.BIOPSYCH.2010.05.030

P1433

Biological Psychiatry

P1476

Microarray analysis of hippoca ...... zheimer's disease progression.

@en

P2093

Anne M Cataldo

http://www.w3.org/2001/XMLSchema#string

Elliott J Mufson

http://www.w3.org/2001/XMLSchema#string

Joanne Wuu

http://www.w3.org/2001/XMLSchema#string

Melissa J Alldred

http://www.w3.org/2001/XMLSchema#string

Rachael L Neve

http://www.w3.org/2001/XMLSchema#string

Ralph A Nixon

http://www.w3.org/2001/XMLSchema#string

Scott E Counts

http://www.w3.org/2001/XMLSchema#string

Shaoli Che

http://www.w3.org/2001/XMLSchema#string

Ying Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

Trk-signaling endosomes are generated by Rac-dependent macroendocytosis.

Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations

β-Amyloid impairs axonal BDNF retrograde trafficking.

Neuroprotection by small molecule activators of the nerve growth factor receptor.

Amplification of RNA transcripts using terminal continuation.

Transcriptional profiling of small samples in the central nervous system

Terminal continuation (TC) RNA amplification without second strand synthesis.

Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition.

P304

885-893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2010.05.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Stephen D Ginsberg

P577

2010-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45286447

http://www.w3.org/2001/XMLSchema#string

P698

20655510

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2965820

http://www.w3.org/2001/XMLSchema#string